Table 3: Patient Outcomes.
| Characteristic | Control number (%) | RUSH protocol number (%) | p |
| LOS, Shock to hospital discharge (days), mean ± SD | 5.9 ± 3.4 | 5.6 ± 3.0 | 0.61 |
| LOS, Shock to ICU discharge (days), mean ± SD | 3.8 ± 3.4 | 4.5 ± 3.1 | 0.26 |
| Mortality | 16 (24.6) | 19 (31.7) | 0.38 |
| Ventilator days, mean ± SD | |||
| AKI Stage (RIFLE) | 0.019 | ||
| Stage 1 | 27 (52.9) | 37 (75.5) | |
| Stage 2 | 0 (0.0) | 0 (0.0) | |
| Stage 3 | 24 (47.1) | 12 (24.5) | |
| New hemodialysis | 9 (13.9) | 5 (8.3) | 0.40 |
| Total IV fluid intake (L), mean ± SD | 13.4 ± 15.3 | 11.5 ± 6.7 | 0.38 |
| Troponin (ng/mL), mean ± SD | 0.61 ± 1.61 | 0.44 ± 1.48 | 0.54 |
| Lactate (mmol/L), mean ± SD | 5.2 ± 4.7 | 4.6 ± 3.7 | 0.48 |
| Total vasopressor support duration, mean ± SD | 80.2 ± 87.9 | 65.5 ± 56.9 | 0.46 |
p: p-values based upon Welch's T-test or Pearson Chi-Square.